TGM3 functions as a tumor suppressor by repressing epithelial‑to‑mesenchymal transition and the PI3K/AKT signaling pathway in colorectal cancer
Yifei Feng(Jiangsu Province Hospital), Ziwei Xu(Capital Medical University), Yueming Sun(Nanjing Medical University), Bing Ji, Yue Zhang(Tongji University), Dongsheng Zhang(Sun Yat-sen University), Jie Li(Purdue University West Lafayette), Yuanjian Huang, Dongjian Ji(Peking University), Chuan Zhang(North Sichuan Medical University), Wen Peng(Jiangsu Cancer Hospital)
Cited by 32
Related Papers
Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway
|Journal of Experimental & Clinical Cancer Research|2019|409
Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial
|The Lancet Oncology|2021|184
A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio
|BMC Cancer|2015|160
Inhibition of the Wnt/β-Catenin Pathway Overcomes Resistance to Enzalutamide in Castration-Resistant Prostate Cancer
|Cancer Research|2018|154
Acetyltransferase NAT10 regulates the Wnt/β-catenin signaling pathway to promote colorectal cancer progression via ac4C acetylation of KIF23 mRNA
|Journal of Experimental & Clinical Cancer Research|2022|146